Author: Lydia Begoña Horndler Gil, Profesor en inmunología y biología del cáncer, Universidad San Jorge

If you’re reading this there’s a good chance that you, like me, are a millennial. If so, you’ve probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later adulthood – hypertension, type 2 diabetes or perhaps even the one that we’re all scared to name: cancer. […]

Personalised medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools. This innovative approach, which involves genetically modifying the cells of the immune system, is transforming the way we treat not only cancer, but also other diseases. The CAR-T revolution is widely documented, with more than […]